“…The 29 studies identified from the full screen included a range of different syndromic surveillance systems from ten countries and territories across Korea, United States, France, Sweden, Netherlands, Spain, Canada, United Kingdom, Japan, and Portugal. Just over half of the studies (52%, 15/29) were reported from the United States and United Kingdom [8,[12][13][14][15][16][17][18][19][20][21][22][23][24][25]. About 55% (16/29) [13,16,[22][23][24][25][26][27][28][29][30][31][32][33][34][35] of the studies indicated that syndromic surveillance exhibited the potential to detect GI infections earlier than traditional surveillance, while a further 10% (3/29) of studies indicated that syndromic surveillance exhibits the potential to detect GI infections or symptoms at an early stage but with limitations [15,20,36]; a further 3% (1/29) highlighted that syndromic surveillance exhibits potential to detect GI infections or symptoms at an early stage only when combined with traditional surveillance system [18].…”